JP2015518368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518368A5 JP2015518368A5 JP2014557603A JP2014557603A JP2015518368A5 JP 2015518368 A5 JP2015518368 A5 JP 2015518368A5 JP 2014557603 A JP2014557603 A JP 2014557603A JP 2014557603 A JP2014557603 A JP 2014557603A JP 2015518368 A5 JP2015518368 A5 JP 2015518368A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- binding protein
- isolated
- antigen binding
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG201201007-0 | 2012-02-13 | ||
| SG2012010070 | 2012-02-13 | ||
| PCT/SG2013/000057 WO2013122544A2 (en) | 2012-02-13 | 2013-02-13 | IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015518368A JP2015518368A (ja) | 2015-07-02 |
| JP2015518368A5 true JP2015518368A5 (enExample) | 2016-03-31 |
| JP6383665B2 JP6383665B2 (ja) | 2018-08-29 |
Family
ID=54261183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557603A Active JP6383665B2 (ja) | 2012-02-13 | 2013-02-13 | ＩＬ‐１β中和ヒトモノクローナル抗体 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US10167335B2 (enExample) |
| EP (2) | EP2814843B1 (enExample) |
| JP (1) | JP6383665B2 (enExample) |
| CN (1) | CN105431452B (enExample) |
| CY (1) | CY1123519T1 (enExample) |
| DK (1) | DK2814843T3 (enExample) |
| ES (1) | ES2798110T3 (enExample) |
| HR (1) | HRP20200964T1 (enExample) |
| HU (1) | HUE049860T2 (enExample) |
| LT (1) | LT2814843T (enExample) |
| PL (1) | PL2814843T3 (enExample) |
| PT (1) | PT2814843T (enExample) |
| RS (1) | RS60583B1 (enExample) |
| SG (2) | SG11201404850SA (enExample) |
| SI (1) | SI2814843T1 (enExample) |
| SM (1) | SMT202000321T1 (enExample) |
| WO (1) | WO2013122544A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105431452B (zh) | 2012-02-13 | 2019-12-31 | 新加坡科技研究局 | 中和IL-1β的人单克隆抗体 |
| CN106928354B (zh) * | 2017-04-25 | 2020-07-17 | 长春金赛药业有限责任公司 | 抗IL-1β单克隆抗体及其应用 |
| AU2018287519B2 (en) * | 2017-06-22 | 2021-07-22 | Novartis Ag | IL-1beta binding antibodies for use in treating cancer |
| CN117024587A (zh) * | 2019-03-07 | 2023-11-10 | 瑞阳(苏州)生物科技有限公司 | 人IL-1β蛋白结合分子及其编码基因和应用 |
| KR102087743B1 (ko) * | 2019-06-10 | 2020-03-12 | 을지대학교 산학협력단 | IL-1beta에 특이적으로 결합하는 항체 및 그의 용도 |
| WO2025006936A2 (en) * | 2023-06-29 | 2025-01-02 | University Of Maine System Board Of Trustees | Methods and compositions for fire-fighting |
| WO2025147459A1 (en) | 2024-01-04 | 2025-07-10 | Nano Precision Medical, Inc. | Stabilization of peptides and proteins in implantable devices and formulations |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US6159937A (en) | 1994-07-05 | 2000-12-12 | Steeno Research Group A/S | Immunomodulators |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US20030007972A1 (en) | 1999-02-24 | 2003-01-09 | Edward Tobinick | Cytokine antagonists and other biologics for the treatment of bone metastases |
| GB0001448D0 (en) | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
| GB0020685D0 (en) | 2000-08-22 | 2000-10-11 | Novartis Ag | Organic compounds |
| EP1332209B1 (en) | 2000-09-08 | 2009-11-11 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| WO2004067568A2 (en) | 2003-01-24 | 2004-08-12 | Applied Molecular Evolution, Inc | Human il-1 beta antagonists |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| CA2531238C (en) | 2003-07-04 | 2015-02-24 | Affibody Ab | Polypeptides having binding affinity for her2 |
| WO2005019255A1 (en) | 2003-08-25 | 2005-03-03 | Pieris Proteolab Ag | Muteins of tear lipocalin |
| KR20060129246A (ko) | 2003-12-05 | 2006-12-15 | 컴파운드 쎄라퓨틱스, 인크. | 타입 2 혈관 내피 성장 인자 수용체의 억제제 |
| EP1851245B1 (en) | 2005-01-26 | 2012-10-10 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| CN101228188A (zh) | 2005-06-21 | 2008-07-23 | 佐马技术有限公司 | IL-1β结合抗体及其片段 |
| TWI395754B (zh) * | 2006-04-24 | 2013-05-11 | Amgen Inc | 人類化之ｃ-ｋｉｔ抗體 |
| EP1958957A1 (en) | 2007-02-16 | 2008-08-20 | NascaCell Technologies AG | Polypeptide comprising a knottin protein moiety |
| TW201124427A (en) | 2009-10-15 | 2011-07-16 | Abbott Lab | IL-1 binding proteins |
| WO2012121679A1 (en) | 2011-03-09 | 2012-09-13 | Agency For Science, Technology And Research | Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage |
| TWI803876B (zh) | 2011-03-28 | 2023-06-01 | 法商賽諾菲公司 | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 |
| CN105431452B (zh) | 2012-02-13 | 2019-12-31 | 新加坡科技研究局 | 中和IL-1β的人单克隆抗体 |
| WO2016008851A1 (en) | 2014-07-14 | 2016-01-21 | Boehringer Ingelheim International Gmbh | Anti-il-1b antibodies |
| AU2016261770B2 (en) | 2015-05-12 | 2022-06-02 | Drexel University | Compounds and compositions useful for treating or preventing cancer metastasis, and methods using same |
| US20180222982A1 (en) | 2015-07-29 | 2018-08-09 | Novartis Ag | Combination therapies comprising antibody molecules to pd-1 |
| US10397741B2 (en) | 2016-11-11 | 2019-08-27 | Shoreline Tracking Systems, LLC | System and method for service tracking |
| AU2018287519B2 (en) | 2017-06-22 | 2021-07-22 | Novartis Ag | IL-1beta binding antibodies for use in treating cancer |
| WO2018235056A1 (en) | 2017-06-22 | 2018-12-27 | Novartis Ag | Il-1beta binding antibodies for use in treating cancer |
| WO2020039401A1 (en) | 2018-08-24 | 2020-02-27 | Novartis Ag | Treatment comprising il-1βeta binding antibodies and combinations thereof |
-
2013
- 2013-02-13 CN CN201380019370.3A patent/CN105431452B/zh active Active
- 2013-02-13 SI SI201331741T patent/SI2814843T1/sl unknown
- 2013-02-13 SM SM20200321T patent/SMT202000321T1/it unknown
- 2013-02-13 RS RS20200680A patent/RS60583B1/sr unknown
- 2013-02-13 HU HUE13748708A patent/HUE049860T2/hu unknown
- 2013-02-13 PL PL13748708T patent/PL2814843T3/pl unknown
- 2013-02-13 HR HRP20200964TT patent/HRP20200964T1/hr unknown
- 2013-02-13 EP EP13748708.8A patent/EP2814843B1/en active Active
- 2013-02-13 DK DK13748708.8T patent/DK2814843T3/da active
- 2013-02-13 LT LTEP13748708.8T patent/LT2814843T/lt unknown
- 2013-02-13 PT PT137487088T patent/PT2814843T/pt unknown
- 2013-02-13 SG SG11201404850SA patent/SG11201404850SA/en unknown
- 2013-02-13 SG SG10201708562VA patent/SG10201708562VA/en unknown
- 2013-02-13 US US14/378,442 patent/US10167335B2/en active Active
- 2013-02-13 WO PCT/SG2013/000057 patent/WO2013122544A2/en not_active Ceased
- 2013-02-13 EP EP20163420.1A patent/EP3736289A1/en not_active Withdrawn
- 2013-02-13 JP JP2014557603A patent/JP6383665B2/ja active Active
- 2013-02-13 ES ES13748708T patent/ES2798110T3/es active Active
-
2018
- 2018-11-15 US US16/192,537 patent/US10919962B2/en active Active
-
2020
- 2020-06-18 CY CY20201100562T patent/CY1123519T1/el unknown
- 2020-10-01 US US17/061,194 patent/US11780913B2/en active Active
-
2021
- 2021-01-15 US US17/150,689 patent/US11912761B2/en active Active
- 2021-01-15 US US17/150,691 patent/US11702471B2/en active Active